Mission
- Warning letter and Written answer
- Third party observation
- Scope confirmation trials
- Invalidation trials (including patent term extension)
- Litigation in Patent court and Supreme court
Acute Airway Inflammation Treatment “Pelubi(Pelubiprofen)” Case (2019Dang4144 etc.) Won Scope Conformation case in tribunal Represented Youngjin, Huons and ChongKunDang |
Morning sickness Treatment “Diclectin (pyridoxine /Doxylamine)” Case (2019Jung80) Won for Opposition of Correction in tribunal Represented Huons |
Overactive bladder Treatment “Betmiga (Mirabegron)” Case (2017Dang558 etc.) Won Scope Conformation case in tribunal Represented ChongKunDang and KyoungDong |
Diabetes Treatment “Trajenta (Linagliptin)” Case (2015Dang1352 etc.) Won Invalidation case in tribunal Represented 4 Korean Pharmaceutical companies including KyungDong |
Dysuria Treatment “Thrupass (Silodosin)” Case (2014dang3375) Won Scope Conformation case in tribunal (Crystal form) Represented ChongKunDang |
Dysuria Treatment “Thrupass (Silodosin)” Case (2014Dang3374) Won Scope Conformation case in tribunal (Formulation) Represented ChongKunDang |
Pain Treatment “Celebrex (Celecoxib)” Case (2014Dang2204) Won Invalidation case in tribunal Represented Yuhan and Boryung |
Hyperlipidemia Treatment “Crestor(Rosuvastatin)” Case (2013Dang2787) Won Invalidation case in tribunal Represented Yuhan |
Diabetes Treatment “Januvia(Sitagliptin)” Case (2015Dang833 etc.) Won Scope Conformation case in tribunal (Hydrate) Represented 8 Korean Pharmaceutical companies including Dasan |
Diabetes Treatment “Januvia(Sitagliptin)” Case (2014Dang3400 etc., 2016Huh991, 2018Hu10589) Won Invalidation case in supreme court (Hydrate) Represented ChongKunDang and YoungJin |
Diabetes Treatment “Januvia(Sitagliptin)” Case (2014Dang3395 etc., 2016Huh984, 2018Hu10572) Won Invalidation case in supreme court (Salt) Represented 8 Korean Pharmaceutical companies including ChongKunDang |
GIST Treatment “Gleevec (Imatinib)” Case (2013Dang688, 2014Huh4913, 2016Hu502) Won Invalidation case in supreme court (Use) Represented Boryung and Jeil |
CML Treatment “Gleevec (Imatinib)” Case (2011Dang2999, 2013Huh4749, 2013Hu3371) Won Invalidation case in supreme court (Formulation) Represented Boryung |
Kyoyeonip│2nd floor, 13, Teheran-ro 70-gil, Gangnam-gu, Seoul, 06194 Republic of Korea │Tel : +82-2-418-5282│ link@kyoyeonip.com
Copyright ⓒ 2021.Kyoyeonip.All rights reserved.
